Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Daly, AU
Christopher N. Daly, Bilgola Plateau AU
| Patent application number | Description | Published |
|---|---|---|
| 20100016922 | CONFIGURATION OF IMPLANTED DEVICES - According to one aspect of the present invention, there is provided an implantable medical device comprising: an implantable component, comprising an implantable memory module, configured to receive and store recipient-specific operating parameters in the implantable memory module, an external component, comprising an external memory module, configured to communicate with the implantable component to receive the recipient-specific operating parameters, and to configure the external component using the recipient-specific operating parameters, wherein the implantable medical device is configured to transfer the recipient-specific operating parameters upon operationally coupling the implantable component with the external component. | 01-21-2010 |
Christopher Newton Daly, Bilgola Plateau AU
| Patent application number | Description | Published |
|---|---|---|
| 20110137377 | COCHLEAR IMPLANT EXTERNAL COMPONENT HAVING A MOVABLE ANTENNA - An external component of a cochlear implant system. The external component includes a support configured to house one or more electronic components and to be mounted to an outer ear of a recipient, and an external antenna configured to provide one or more of power and data signals from the electronic components to an implantable component of the cochlear implant system, wherein the external antenna is mounted to the support such that the external antenna moveable relative to at least a portion of the support. | 06-09-2011 |
Christopher Newton Daly, Newport AU
| Patent application number | Description | Published |
|---|---|---|
| 20100100003 | MONITORING SYSTEM - A method for performing impedance measurements on a subject. The method includes, in a processing system, causing at least one electrical signal to be applied to the subject via first leads operatively connected to first electrodes provided on the subject, determining a first indication indicative of at least one first electrical signal measured via second leads operatively disconnected from second electrodes positioned on the subject, determining a second indication indicative of at least one second electrical signal measured via second leads operatively connected to second electrodes positioned on the subject, and determining from the indications and the at least one applied signal, at least one instantaneous impedance value. | 04-22-2010 |
| 20100168530 | MEASUREMENT APPARATUS - A method for determining biological indicators, the method including, in a processing system causing at least one radiation attenuation measurement to be performed and determining at least one first biological indicator using determined radiation attenuation. In addition to this, method includes causing at least one impedance measurement to be performed and determining at least one second biological indicator using a determined impedance measurement. | 07-01-2010 |
| 20110025348 | IMPEDANCE DETERMINATION - Apparatus for use in performing impedance measurements on a subject. The apparatus includes a processing system for causing a first signal to be applied to the subject, determining an indication of a second signal measured across the subject, using the indication of the second signal to determine any imbalance and if an imbalance exists, determining a modified first signal in accordance with the imbalance and causing the modified first signal to be applied to the subject to thereby allow at least one impedance measurement to be performed. | 02-03-2011 |
Geoffrey Daniel Daly, Sherwood AU
| Patent application number | Description | Published |
|---|---|---|
| 20090287152 | Burette - A burette ( | 11-19-2009 |
Geoffrey Daniel Daly, Queensland AU
| Patent application number | Description | Published |
|---|---|---|
| 20090118671 | Retractable needle device - A retractable needle device to be attached to the forward end of a syringe. The device has a forward end with a needle assembly that is urged into the body of the device so that when the syringe and device are to be discarded, the needle is located internally of the body of the device to inhibit needles stick injuries. | 05-07-2009 |
| 20110112485 | FLUSHABLE INJECTION PORT - The combination ( | 05-12-2011 |
John Michael Daly, City Beach AU
| Patent application number | Description | Published |
|---|---|---|
| 20090241204 | TRANSGENIC NON-HUMAN ANIMALS FOR PHARMACOLOGICAL AND TOXICOLOGICAL STUDIES - The present invention is directed to the production, breeding and use of transgenic non-human animals such as mice in which specific genes or portions of genes have been replaced by homologues from another animal to make the physiology of the animals so modified more like that of the other animal with respect to drug pharmacokinetics and metabolism. The invention also extends to the use of the genetically modified non-human animals of the invention for pharmacological and/or toxicological studies. | 09-24-2009 |
| 20100055693 | LUCIFERASE SIGNAL ENHANCING COMPOSITIONS - Reagents and compositions for use in reactions catalysed by luciferase enzymes, and in particular for use in luciferase-based gene reporter assays are described. The invention also provides methods and compositions for, inter alia, increasing the sensitivity and/or improving the kinetics of luciferase-catalysed reactions. | 03-04-2010 |
| 20100092967 | BIOLUMINESCENT ASSAYS UTILISING SECRETED LUCIFERASES - Disclosed herein are methods for determining the amount or activity of one or more luciferases and methods for measuring the luminescent signal generated by one or more luciferases in a sample, the methods comprising incubating the sample with a reactive substrate(s) of the luciferase(s) to be analysed and a reducing agent to inactivate a first luciferase, wherein the first luciferase, in its native form, is a secreted luciferase. | 04-15-2010 |
| 20100319076 | TRANSGENIC NON-HUMAN ANIMALS FOR PHARMACOLOGICAL AND TOXICOLOGICAL STUDIES - The present invention is directed to the production, breeding and use of transgenic non-human animals such as mice in which specific genes or portions of genes have been replaced by homologues from another animal to make the physiology of the animals so modified more like that of the other animal with respect to drug pharmacokinetics and metabolism. The invention also extends to the use of the genetically modified non-human animals of the invention for pharmacological and/or toxicological studies. | 12-16-2010 |
Kerry Daly, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20110201105 | LACTATION-ASSOCIATED POLYPEPTIDES - The invention relates to cDNA libraries obtained from Tammar wallaby ( | 08-18-2011 |
Norelle Lee Daly, Kenmore AU
| Patent application number | Description | Published |
|---|---|---|
| 20100298528 | Cystine knot molecules - The present invention relates generally to a molecular framework having a cyclic structure. More particularly, the present invention provides cyclic proteins and derivatives thereof in which particular turns and other elements of the molecular structure are held in defined orientations with respect to each other. The cyclic proteins of the present invention provide a molecular framework for the introduction of particular amino acids or heterologous amino acid sequences to facilitate the presentation of biological activities associated with these heterologous amino acid sequences. The molecular framework of the present invention may be naturally cyclic or may be a cyclized derivative of a linear molecular or may be a linear derivative of a cyclized molecule. The present invention contemplates the use of the molecular framework with or without particular amino acids inserted or substituted thereon for the treatment of or prophylaxis of disease conditions in animals, mammals (including humans) and plants. | 11-25-2010 |
Rachel Daly, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20090143529 | Peptide purification by means of hard metal ion affinity chromatography - A polymer substrate functionalized with a functionality comprising at least one cyclic, metal ion coordinating ligand group which comprises at least 3 nitrogen donor atoms in the ring of the cyclic group, at least one of the nitrogen atoms having an optionally substituted carboxy(lower alkyl) or optionally substituted phosphono(lower alkyl) group covalently attached thereto, is well suited for use in conjunction with “hard” metal ions of low toxicity (such as Ca | 06-04-2009 |